https://auntresodamid.com/iJugHxINePLH1VY/96561

Breaking News: Business

Even at  million per Super Bowl commercial, ad executives say it’s still bang for your buck

Even at $8 million per Super Bowl commercial, ad executives say it’s still bang for your buck

NEW ORLEANS, LOUISIANA – FEBRUARY 03: A detailed view of drink koozies seen during an event ahead of Super Bowl LIX at Caesars Superdome on February 03, 2025 in New Orleans, Louisiana. (Photo by Jonathan Bachman/Getty Images) Jonathan Bachman | Getty Images Sport | Getty Images Advertisers shelled out up to $8 million for a […]

Even at $8 million per Super Bowl commercial, ad executives say it’s still bang for your buck Read More »

As the war on DEI intensifies, some companies hold the line while others work behind the scenes

As the war on DEI intensifies, some companies hold the line while others work behind the scenes

President Donald Trump speaks during a press conference at the White House in Washington, D.C., Jan. 30, 2025. Xinhua News Agency | Xinhua News Agency | Getty Images There’s a delicate balance playing out at corporations across America. As the Trump administration targets diversity, equity and inclusion initiatives, many prominent companies have publicly scaled back

As the war on DEI intensifies, some companies hold the line while others work behind the scenes Read More »

Denver Broncos President Damani Leech praises NFL’s diversity commitment as corporate America, government roll back DEI

Denver Broncos President Damani Leech praises NFL’s diversity commitment as corporate America, government roll back DEI

Denver Broncos President Damani Leech praised the NFL’s commitment to diversity amid corporate and government efforts to reduce diversity, equity and inclusion hiring practices. Leech is one of four African American presidents of NFL teams. “I think we’ve all been hired in the last three to four years,” Leech told CNBC Sport from Radio Row

Denver Broncos President Damani Leech praises NFL’s diversity commitment as corporate America, government roll back DEI Read More »

E.l.f. Beauty CEO says company is ‘relieved’ China tariffs are only 10%

E.l.f. Beauty CEO says company is ‘relieved’ China tariffs are only 10%

The New York Stock Exchange welcomes E.l.f. Beauty on March 18, 2024, to celebrate its 20th anniversary of founding. The CEO of E.l.f. Beauty, which manufactures about 80% of its cosmetics in China, told CNBC on Thursday that it was “relieved” the new tariff on Chinese imports is only 10%. The retailer isn’t sure yet

E.l.f. Beauty CEO says company is ‘relieved’ China tariffs are only 10% Read More »

E.l.f. cuts guidance after ‘soft’ January, citing TikTok ban saga and LA wildfires as headwinds

E.l.f. cuts guidance after ‘soft’ January, citing TikTok ban saga and LA wildfires as headwinds

Elf complexion sponges arranged in Germantown, New York, July 17, 2023. Gabby Jones | Bloomberg | Getty Images E.l.f. Beauty on Thursday cut its full-year guidance after seeing a 36% drop in profits and “softer than expected” sales trends in January, marking a rare downturn for one of beauty’s hottest brands.  The cosmetics company reported

E.l.f. cuts guidance after ‘soft’ January, citing TikTok ban saga and LA wildfires as headwinds Read More »

Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected

Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected

The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024.  Ore Huiying | Bloomberg | Getty Images Eli Lilly on Thursday said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide later this year, a few months

Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected Read More »

Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short

Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short

Eli Lilly on Thursday reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared. The company’s quarterly earnings topped Wall Street estimates, but sales fell just short as Mounjaro saw lower realized prices. Zepbound and Mounjaro have now underperformed expectations for two straight

Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short Read More »

Shares of Peloton surge 13% as it edges closer to profitability, posts better than expected sales

Shares of Peloton surge 13% as it edges closer to profitability, posts better than expected sales

Peloton told investors Thursday it still has a “steep hill to climb” to achieve profitable growth under its new CEO, but the connected fitness company beat holiday sales expectations, thanks in part to its partnership with Costco.  The bike maker posted mixed fiscal second-quarter results, as it topped Wall Street’s sales estimates but lost more

Shares of Peloton surge 13% as it edges closer to profitability, posts better than expected sales Read More »

Don’t miss latest news!

Select list(s):

We don’t spam! Read our [link]privacy policy[/link] for more info.

Scroll to Top